Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Tenosynovitis With Psammomatous Calcifications: A Distinctive Trauma-Associated Subtype of Idiopathic Calcifying Tenosynovitis With a Predilection for the Distal extremities of Middle-Aged Women-A Report of 23 Cases.

Michal M, Agaimy A, Folpe AL, Zambo I, Kebrle R, Horch RE, Kinkor Z, Svajdler M, Vanecek T, Heidenreich F, Kazakov DV, Michalova K, Hadravsky L, Michal M.

Am J Surg Pathol. 2019 Feb;43(2):261-267. doi: 10.1097/PAS.0000000000001182.

PMID:
30371510
2.

T-cell receptor-α repertoire of CD8+ T cells following allogeneic stem cell transplantation using next-generation sequencing.

Link-Rachner CS, Eugster A, Rücker-Braun E, Heidenreich F, Oelschlägel U, Dahl A, Klesse C, Kuhn M, Middeke JM, Bornhäuser M, Bonifacio E, Schetelig J.

Haematologica. 2019 Mar;104(3):622-631. doi: 10.3324/haematol.2018.199802. Epub 2018 Sep 27.

3.

Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.

Teipel R, Oelschlägel U, Wetzko K, Schmiedgen M, Kramer M, Rücker-Braun E, Hölig K, von Bonin M, Heidrich K, Fuchs A, Ordemann R, Kroschinsky F, Bornhäuser M, Hütter G, Schmidt H, Ehninger G, Schetelig J, Heidenreich F.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2171-2177. doi: 10.1016/j.bbmt.2018.06.023. Epub 2018 Jun 21.

PMID:
29935214
4.

Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.

Schmidt JR, Rücker-Braun E, Heidrich K, von Bonin M, Stölzel F, Thiede C, Middeke JM, Ehninger G, Bornhäuser M, Schetelig J, Schubert K, von Bergen M, Heidenreich F.

Proteomes. 2018 Feb 12;6(1). pii: E11. doi: 10.3390/proteomes6010011.

5.

Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells.

Heidenreich F, Rücker-Braun E, Walz JS, Eugster A, Kühn D, Dietz S, Nelde A, Tunger A, Wehner R, Link CS, Middeke JM, Stölzel F, Tonn T, Stevanovic S, Rammensee HG, Bonifacio E, Bachmann M, Zeis M, Ehninger G, Bornhäuser M, Schetelig J, Schmitz M.

Haematologica. 2017 Nov;102(11):e460-e464. doi: 10.3324/haematol.2017.167312. Epub 2017 Aug 24. No abstract available.

6.

Assessment of the T cell receptor repertoire in long-term platelet donors by next generation sequencing.

Link CS, Hölig K, Rücker-Braun E, Lang K, Kuhn M, Eugster A, Klesse C, Schmiedgen M, Heidenreich F, Oelschlägel U, Dahl A, Bornhäuser M, Bonifacio E, Schetelig J.

Br J Haematol. 2018 May;181(3):389-391. doi: 10.1111/bjh.14576. Epub 2017 Mar 8. No abstract available.

PMID:
28272738
7.

[Diffuse tenosynovial giant cell tumor of the cervical spine destroying vertebra C6 - a case report].

Kinkor Z, Svoboda T, Grossman P, Bludovský D, Heidenreich F, Švec A, Mečiarová I.

Cesk Patol. Fall 2016;52(4):218-221. Czech.

PMID:
27869449
8.

Generation of high-avidity, WT1-reactive CD8+ cytotoxic T cell clones with anti-leukemic activity by streptamer technology.

Tunger A, Wehner R, von Bonin M, Kühn D, Heidenreich F, Matko S, Nauerth M, Rücker-Braun E, Dietz S, Link CS, Eugster A, Odendahl M, Busch DH, Tonn T, Bonifacio E, Germeroth L, Schetelig J, Bachmann MP, Bornhäuser M, Schmitz M.

Leuk Lymphoma. 2017 May;58(5):1246-1249. doi: 10.1080/10428194.2016.1233538. Epub 2016 Nov 16. No abstract available.

PMID:
27852136
9.

Longitudinal analyses of leukemia-associated antigen-specific CD8+ T cells in patients after allogeneic stem cell transplantation.

Rücker-Braun E, Link CS, Schmiedgen M, Tunger A, Vizjak P, Teipel R, Wehner R, Kühn D, Fuchs YF, Oelschlägel U, Germeroth L, Schmitz M, Bornhäuser M, Schetelig J, Heidenreich F.

Exp Hematol. 2016 Nov;44(11):1024-1033.e1. doi: 10.1016/j.exphem.2016.07.008. Epub 2016 Jul 26.

PMID:
27473564
10.

Mixed epithelial and stromal tumor of the middle ear: The first case report.

Michal M, Skálová A, Kazakov DV, Pecková K, Heidenreich F, Grossmann P, Michal M.

Hum Pathol. 2017 Mar;61:199-204. doi: 10.1016/j.humpath.2016.09.020. Epub 2016 Oct 13.

PMID:
27746270
11.

Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.

Link CS, Eugster A, Heidenreich F, Rücker-Braun E, Schmiedgen M, Oelschlägel U, Kühn D, Dietz S, Fuchs Y, Dahl A, Domingues AM, Klesse C, Schmitz M, Ehninger G, Bornhäuser M, Schetelig J, Bonifacio E.

Clin Exp Immunol. 2016 Jun;184(3):389-402. doi: 10.1111/cei.12770. Epub 2016 Mar 8.

12.

TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.

Middeke JM, Herold S, Rücker-Braun E, Berdel WE, Stelljes M, Kaufmann M, Schäfer-Eckart K, Baldus CD, Stuhlmann R, Ho AD, Einsele H, Rösler W, Serve H, Hänel M, Sohlbach K, Klesse C, Mohr B, Heidenreich F, Stölzel F, Röllig C, Platzbecker U, Ehninger G, Bornhäuser M, Thiede C, Schetelig J; Study Alliance Leukaemia (SAL).

Br J Haematol. 2016 Mar;172(6):914-22. doi: 10.1111/bjh.13912. Epub 2016 Jan 13.

PMID:
26771088
13.

Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation.

Link CS, Teipel R, Heidenreich F, Rücker-Braun E, Schmiedgen M, Reinhardt J, Oelschlägel U, von Bonin M, Middeke JM, Muetherig A, Trautmann-Grill K, Platzbecker U, Bornhäuser M, Schetelig J.

Bone Marrow Transplant. 2016 Jun;51(6):793-8. doi: 10.1038/bmt.2015.339. Epub 2016 Jan 11.

PMID:
26752141
14.

[Choledochal cyst].

Zeithaml J, Třeška V, Moláček J, Heidenreich F.

Rozhl Chir. 2015 Sep;94(9):379-82. Czech.

PMID:
26537103
15.

Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?

Heidenreich F.

J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1171. doi: 10.1136/jnnp-2015-310763. Epub 2015 Sep 16. No abstract available.

PMID:
26377620
16.

Neuronal Na+/K+ ATPase is an autoantibody target in paraneoplastic neurologic syndrome.

Scharf M, Miske R, Heidenreich F, Giess R, Landwehr P, Blöcker IM, Begemann N, Denno Y, Tiede S, Dähnrich C, Schlumberger W, Unger M, Teegen B, Stöcker W, Probst C, Komorowski L.

Neurology. 2015 Apr 21;84(16):1673-9. doi: 10.1212/WNL.0000000000001493. Epub 2015 Mar 25.

PMID:
25809299
17.

Proteomic and functional consequences of hexokinase deficiency in glucose-repressible Kluyveromyces lactis.

Mates N, Kettner K, Heidenreich F, Pursche T, Migotti R, Kahlert G, Kuhlisch E, Breunig KD, Schellenberger W, Dittmar G, Hoflack B, Kriegel TM.

Mol Cell Proteomics. 2014 Mar;13(3):860-75. doi: 10.1074/mcp.M113.032714. Epub 2014 Jan 16.

18.

Educational campaign on stroke in an urban population in Northern Germany: influence on public stroke awareness and knowledge.

Worthmann H, Schwartz A, Heidenreich F, Sindern E, Lorenz R, Adams HA, Flemming A, Luettje K, Walter U, Haertle B, Dengler R.

Int J Stroke. 2013 Jul;8(5):286-92. doi: 10.1111/j.1747-4949.2012.00809.x. Epub 2012 May 9.

PMID:
22568388
19.

Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.

Hong B, Wiese B, Bremer M, Heissler HE, Heidenreich F, Krauss JK, Nakamura M.

Am J Clin Oncol. 2013 Jun;36(3):261-8. doi: 10.1097/COC.0b013e3182467bb1.

PMID:
22495452
20.

Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis.

Rieckmann P, Heidenreich F, Sailer M, Zettl UK, Zessack N, Hartung HP, Gold R.

Ther Adv Neurol Disord. 2012 Jan;5(1):3-12. doi: 10.1177/1756285611428503.

21.

Identification of increased amounts of eppin protein complex components in sperm cells of diabetic and obese individuals by difference gel electrophoresis.

Paasch U, Heidenreich F, Pursche T, Kuhlisch E, Kettner K, Grunewald S, Kratzsch J, Dittmar G, Glander HJ, Hoflack B, Kriegel TM.

Mol Cell Proteomics. 2011 Aug;10(8):M110.007187. doi: 10.1074/mcp.M110.007187. Epub 2011 Apr 27.

22.

Identification of diabetes- and obesity-associated proteomic changes in human spermatozoa by difference gel electrophoresis.

Kriegel TM, Heidenreich F, Kettner K, Pursche T, Hoflack B, Grunewald S, Poenicke K, Glander HJ, Paasch U.

Reprod Biomed Online. 2009 Nov;19(5):660-70.

PMID:
20021714
23.

Paraneoplastic autoimmune encephalitis associated with CV2/CRMP-5 IgG antineuronal antibodies in a patient with thymoma.

Werry C, Götz F, Wurster U, Stangel M, Giess R, Heidenreich F, Windhagen A.

J Neurol. 2009 Jan;256(1):129-31. doi: 10.1007/s00415-009-0826-1. Epub 2009 Feb 16. No abstract available.

PMID:
19267170
24.

Interferon-induced Mx proteins in brain tissue of multiple sclerosis patients.

Al-Masri AN, Heidenreich F, Walter GF.

Eur J Neurol. 2009 Jun;16(6):721-6. doi: 10.1111/j.1468-1331.2009.02573.x. Epub 2009 Feb 19.

PMID:
19236454
25.

[Intracerebral calcinosis as intra-axial manifestation of scleroderma en coup de sabre].

Wagner M, Wiese B, Heidenreich F, Lanfermann H, Landwehr P.

Rofo. 2008 Jun;180(6):563-4. doi: 10.1055/s-2008-1027247. German. No abstract available. Erratum in: Rofo. 2008 Jul;180(7):663.

PMID:
18504667
26.

Up-regulation of platelet-derived growth factor by peripheral-blood leukocytes during experimental allergic encephalomyelitis.

Koehler NK, Roebbert M, Dehghani K, Ballmaier M, Claus P, von Hoersten S, Shing M, Odin P, Strehlau J, Heidenreich F.

J Neurosci Res. 2008 Feb 1;86(2):392-402.

PMID:
17893914
27.

Alemtuzumab depletes dendritic cells more effectively in blood than in skin: a pilot study in patients with chronic lymphocytic leukemia.

Auffermann-Gretzinger S, Eger L, Schetelig J, Bornhäuser M, Heidenreich F, Ehninger G.

Transplantation. 2007 May 15;83(9):1268-72.

PMID:
17496545
28.

Comprehensive treatment of late-onset tibia vara.

Gordon JE, Heidenreich FP, Carpenter CJ, Kelly-Hahn J, Schoenecker PL.

J Bone Joint Surg Am. 2005 Jul;87(7):1561-70.

PMID:
15995124
29.

[Finding a meaning for illness: from medical anthropology to cultural epidemiology].

Taïeb O, Heidenreich F, Baubet T, Moro MR.

Med Mal Infect. 2005 Apr;35(4):173-85. Epub 2005 Apr 20. Review. French.

PMID:
15914285
30.

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group.

J Neurol. 2004 Nov;251(11):1329-39. Review.

PMID:
15592728
31.

MRI after thoracic epidural blood patch.

Giess R, Landwehr P, Heidenreich F.

Neurology. 2003 Nov 25;61(10):1449. No abstract available.

PMID:
14638978
32.

Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.

Balcer LJ, Baier ML, Cohen JA, Kooijmans MF, Sandrock AW, Nano-Schiavi ML, Pfohl DC, Mills M, Bowen J, Ford C, Heidenreich FR, Jacobs DA, Markowitz CE, Stuart WH, Ying GS, Galetta SL, Maguire MG, Cutter GR.

Neurology. 2003 Nov 25;61(10):1367-73.

PMID:
14638957
33.

Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis.

Wiesemann E, Klatt J, Wenzel C, Heidenreich F, Windhagen A.

Clin Exp Immunol. 2003 Sep;133(3):454-60.

34.

Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Kooijmans MF, Sandrock AW, Rudick RA, Simon JH, Simonian NA, Tsao EC, Whitaker JN; IMPACT Investigators.

Neurology. 2002 Sep 10;59(5):679-87.

PMID:
12221157
35.
36.

Successful treatment of a spontaneous cervical cerebrospinal fluid leak with a CT guided epidural blood patch.

Dillo W, Hollenhorst J, Brassel F, von Hof-Strobach K, Heidenreich F, Johannes S.

J Neurol. 2002 Feb;249(2):224-5. No abstract available.

PMID:
11985392
37.

[Lipomatosis dolorosa--a frequently overlooked disease picture].

Steiner J, Schiltz K, Heidenreich F, Weissenborn K.

Nervenarzt. 2002 Feb;73(2):183-7. German.

PMID:
11975097
38.

Interferon-beta increases the stimulatory capacity of monocyte-derived dendritic cells to induce IL-13, IL-5 and IL-10 in autologous T-cells.

Wiesemann E, Sönmez D, Heidenreich F, Windhagen A.

J Neuroimmunol. 2002 Feb;123(1-2):160-9.

PMID:
11880160
39.

[Primary angiitis of CNS (PACNS)].

Rollnik JD, Brandis A, Dehghani K, Bufler J, Lorenz M, Heidenreich F, Donnerstag F.

Nervenarzt. 2001 Oct;72(10):798-801. Review. German.

PMID:
11688183
40.

Therapeutic options for meningeal melanocytoma. Case report.

Rades D, Heidenreich F, Tatagiba M, Brandis A, Karstens JH.

J Neurosurg. 2001 Oct;95(2 Suppl):225-31.

PMID:
11599841
41.

Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells.

Wiesemann E, Klatt J, Sönmez D, Blasczyk R, Heidenreich F, Windhagen A.

J Neuroimmunol. 2001 Sep 3;119(1):137-44.

PMID:
11525811
42.

Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Jak AJ, Kniker JE, Kooijmans MF, Lull JM, Sandrock AW, Simon JH, Simonian NA, Whitaker JN.

Arch Neurol. 2001 Jun;58(6):961-7.

PMID:
11405811
44.

Unusual presentation of a primary spinal Burkitt's lymphoma.

Wilkening A, Brack M, Brandis A, Heidenreich F, Dengler R, Weibetaenborn K.

J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):794-7.

45.

The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls.

Haase CG, Guggenmos J, Brehm U, Andersson M, Olsson T, Reindl M, Schneidewind JM, Zettl UK, Heidenreich F, Berger T, Wekerle H, Hohlfeld R, Linington C.

J Neuroimmunol. 2001 Mar 1;114(1-2):220-5.

PMID:
11240035
46.

Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate.

Windhagen A, Maniak S, Marckmann S, Lindert RB, Heidenreich F, Blasczyk R.

J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):415-6. No abstract available.

47.

Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome.

Buchwald B, Bufler J, Carpo M, Heidenreich F, Pitz R, Dudel J, Nobile-Orazio E, Toyka KV.

Neurology. 2001 Jan 9;56(1):67-74.

PMID:
11148238
48.

[Oculopharyngeal muscle dystrophy. Genetic diagnosis in a family in Germany].

Mohammadi B, Bufler J, Kress W, Brandis A, Walter GF, Dengler R, Heidenreich F.

Nervenarzt. 2000 Dec;71(12):1003-6. German.

PMID:
11139982
49.

Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one-year results of a prospective trial.

Rades D, Blach M, Bremer M, Wildfang I, Karstens JH, Heidenreich F.

Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1403-8.

PMID:
11121640
50.

A point mutation in PTPRC is associated with the development of multiple sclerosis.

Jacobsen M, Schweer D, Ziegler A, Gaber R, Schock S, Schwinzer R, Wonigeit K, Lindert RB, Kantarci O, Schaefer-Klein J, Schipper HI, Oertel WH, Heidenreich F, Weinshenker BG, Sommer N, Hemmer B.

Nat Genet. 2000 Dec;26(4):495-9.

PMID:
11101853

Supplemental Content

Loading ...
Support Center